The biotechnology industry's daily news monitor, with emphasis on clinical stage drug development, FDA/EMEA regulations, drug licensing pacts, and M&A involving developers.
Audience:   Senior business executives and clinical operations leaders at biotech, pharmaceutical, and related drug development companies.

Key Topics: Clinical stage drug development, FDA/EMEA regulations, drug licensing pacts, mergers & acquisitions involving developers, biotech & pharma deals

Newsletter Frequency: Daily

Email Subscribers: 100,000+

Monthly page views: 550,260

Reader Demographics

Company Type
Biotechnology - 25%
Pharmaceutical - 23%
CRO/CMO/Contract Outsourcing - 20%
Healthcare/Medical - 5%
Financial/Legal - 3%
Marketing / Ad Agency - 3%
Devices/Diagnostics - 3%
IT/IS/Bioinformatics - 2%
Instruments/Materials - 2%
Government - 1%
Other - 12%

Job Function
CEO / C-Level Executive - 20%
Licensing / Biz Dev - 12%
Sales - 11%
Clinical Operations - 10%
Branding / Marketing - 7%
R&D / Engineering - 6%
IT / IS / Bioinformatics - 6%
Regulatory / Compliance / Safety - 4%
Finance / Legal - 4%
Manufacturing / Packaging - 3%
QA / QC - 2%
Medical Affairs - 2%
Other - 13%

Region
North America - 73%
Europe - 10%
Asia - 10%
Australia/NZ - 1%
Other - 6%

FierceBiotech readers who recommend or approve purchasing
Lab Supplies & Equipment - 41%
Outsourcing Partners - CROs - 36%
Outsourcing Partners - other - 43%
IT/Software - 31%
Legal/Patent Services - 32%
Financial/Accounting Services - 26%

View Rates

Enter your contact information to see current rates and packages.

Top Companies Represented

Abbot Laboratories
Amgen
Aventis
Barr Laboratories
Bayer
BIO
Biogen IDC
Boehringer Ingelheim
Bristol Myers Squibb
Cambrex
Celera Genomics
Celgene
Centocor
Charles River Laboratories
Chiron
Eli Lilly
Elsevier
EMD Biosciences
Exelixis
Fischer Scientific
Genentech
Genzyme
GlaxoSmithKline
Ingenix
Invitrogen
Johnson & Johnson
MedImmune
Medtronic
Merck
Neurocrine Biosciences
Novartis
Pfizer
Quintiles
Regeneron Pharmaceuticals
Sanofi-Aventis
Schering-Plough
Theravance, Inc.
Therion Biologics
Wyeth BioPharma
Xencor, Inc.
ZymoGenetics